Purchase Order 75N98026P00205

<p>The NIH Clinical Center awarded a purchase order to One Lambda, Inc. valued at $615,447.36 on June 1, 2026, for HLA typing and antibody screening reagents to support the HLA Lab on a regular basis. Place of performance is Bethesda, Maryland. The order carries a firm fixed price and ultimate completion date of September 30, 2026. No set-aside was used.</p>

The NIH Clinical Center issued a delivery order to One Lambda, Inc. on August 6, 2020, for various HLS typing and antibody screening reagents, with a ceiling value of $617,196.90. Place of performance is Canoga Park, CA. The order was issued on a firm fixed-price basis with an ultimate completion date of July 31, 2021. The award was made to de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) in preparation for the September 30, 2026 closing...

The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $691,214.50 firm-fixed-price delivery order to One Lambda, Inc., a for-profit manufacturer of medical testing reagents and supplies. The contract is for the delivery of various human leukocyte antigen (HLA) typing and antibody screening reagents used in diagnostics, research protocols, and maintaining accreditation at the NIH Clinical Center. One Lambda is a subsidiary of Thermo Electron...

The Department of Health and Human Services National Institutes of Health Clinical Center (HHS-NIH) awarded a $677,035.53 firm fixed price delivery order contract to One Lambda Inc., a subsidiary of Thermo Electron Corporation Financial Services Division, to provide various reagents from August 1, 2023 through July 31, 2024. The place of performance will be One Lambda's facility located in Canoga Park, California. No subcontractors were identified. The reagents will likely support medical...

The Department of Health and Human Services National Institutes of Health Clinical Center (HHS-NIH) awarded a $653,880.75 firm fixed price delivery order contract to One Lambda Inc., a subsidiary of Thermo Electron Corporation Financial Services Division, to provide various reagents from July 6, 2022 through July 31, 2023. The place of performance will be One Lambda's facility located in Canoga Park, California. No subcontractors were identified. One Lambda is a leading provider of immunogenetic...

<p>The NIH Clinical Center awarded a purchase order to Omixon, Inc. for $10,165.00 on April 28, 2021, to supply HLA testing reagents for the Department of Transfusion Medicine. Work is performed at the vendor's location in Cambridge, Massachusetts. The order is firm fixed price with no set-aside. Ultimate completion date is May 10, 2021.</p>

This is a firm-fixed-price purchase order awarded by the National Institutes of Health (NIH) to One Lambda, Inc., a subsidiary of Thermo Electron Corporation, for the supply of a LABScan 3D instrument, an advanced multiplex analyzer, to be used by the NIH Human Leukocyte Antigen (HLA) Laboratory. The purchase order, valued at $75,859.17, is being made on a sole-source basis under the authority of FAR Subpart 13.106-1(b)(i) due to the need for compatibility with the lab's existing procedures...

Veterans Integrated Service Network 23 issued a delivery order to One Lambda, Inc. on October 1, 2025, with a ceiling value of $1,260,129.37 for reagents under firm fixed price terms. This is the first ordering period delivery order against One Lambda's Indefinite Delivery Contract with Veterans Integrated Service Network 23. Place of performance is West Hills, CA. The order is scheduled for ultimate completion on September 30, 2026. One Lambda manufactures immunogenetic and transplant...

The Defense Health Agency awarded a purchase order to One Lambda, Inc. for HistoTrac software maintenance with a ceiling value of $28,611.29, effective March 12, 2026 and completing March 11, 2029. Performance occurs at Bethesda, Maryland. The order is firm fixed price with no set-aside category. One Lambda is a for-profit manufacturer of medical testing reagents and diagnostic products specializing in immunogenetic and transplant diagnostic testing solutions, including human leukocyte antigen...

<p>The NIH Clinical Center awarded a purchase order to Life Technologies Corporation on April 7, 2026, with a ceiling value of $70,000.00 and an ultimate completion date of September 30, 2026. Performance takes place in Grand Island, New York. The order is priced on a firm fixed-price basis and carries no set-aside designation.</p>